Pardeep S Jhund

Pardeep S Jhund

UNVERIFIED PROFILE

Are you Pardeep S Jhund?   Register this Author

Register author
Pardeep S Jhund

Pardeep S Jhund

Publications by authors named "Pardeep S Jhund"

Are you Pardeep S Jhund?   Register this Author

100Publications

2752Reads

7Profile Views

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction.

JACC Heart Fail 2020 Mar 8;8(3):188-198. Epub 2020 Jan 8.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.09.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086149PMC
March 2020

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. Reply.

N Engl J Med 2020 03;382(10):973

University of Glasgow, Glasgow, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1917241DOI Listing
March 2020

Covariate adjusted reanalysis of the I-Preserve trial.

Clin Res Cardiol 2020 Mar 25. Epub 2020 Mar 25.

BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-020-01632-xDOI Listing
March 2020

A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction.

Eur Heart J 2020 Mar 28. Epub 2020 Mar 28.

Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehaa184DOI Listing
March 2020

The recurring problem of heart failure hospitalisations.

Authors:
Pardeep S Jhund

Eur J Heart Fail 2020 Feb 11;22(2):249-250. Epub 2020 Jan 11.

British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1721DOI Listing
February 2020

Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.

Circ Heart Fail 2020 Feb 17;13(2):e006541. Epub 2020 Feb 17.

BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (R.R., P.S.J., S.L.K., P.W., J.J.V.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.119.006541DOI Listing
February 2020

The Dapagliflozin And Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context.

Eur Heart J 2020 Jan 3. Epub 2020 Jan 3.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz916DOI Listing
January 2020

The price of a failing heart.

Eur J Heart Fail 2019 Dec 9;21(12):1532-1533. Epub 2019 Dec 9.

British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1605DOI Listing
December 2019

Physiological monitoring of the complex multimorbid heart failure patient - diabetes and monitoring glucose control.

Eur Heart J Suppl 2019 Dec 31;21(Suppl M):M20-M24. Epub 2019 Dec 31.

British Heart Foundation Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/suz219DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937507PMC
December 2019

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.

N Engl J Med 2019 11 19;381(21):1995-2008. Epub 2019 Sep 19.

From the BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (J.J.V.M., M.C.P., K.F.D., P.S.J.); the Cardiovascular Division (S.D.S., A.S.D.) and the TIMI Study Group, Brigham and Women's Hospital and Harvard Medical School (M.S.S.) - all in Boston; Section of Endocrinology, Yale University School of Medicine, New Haven, CT (S.E.I.); Rigshospitalet Copenhagen University Hospital (L.K.) and the Department of Cardiology, Gentofte University Hospital (M. Schou), Copenhagen; the Department of Medicine, Saarland University Hospital, Homburg-Saar, Germany (M.B.); Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.); National University of Cordoba, Cordoba (F.A.M.), and the Division of Cardiology, Instituto Cardiovascular de Buenos Aires, Buenos Aires (M.D.) - both in Argentina; Wroclaw Medical University, Wroclaw (P.P.), and the Department of Cardiology, Medical University of Lodz, Lodz (J.D.) - both in Poland; the Department of Cardiology, University of Minnesota, Minneapolis (I.S.A.); 2nd Department of Internal Medicine, Cardiovascular Medicine, General Teaching Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic (J.B.); the Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan (C.-E.C.); the Department of Cardiology, Medanta, Gurgaon, India (V.K.C.); the Department of Cardiology, University Medical Center and University of Groningen, Groningen, the Netherlands (R.A.B.); the 5th Department of Internal Medicine, Comenius University in Bratislava, Bratislava, Slovakia (A.D.); the Department of Cardiology, Shanghai Institute of Cardiovascular Disease and Zhongshan Hospital Fudan University, Shanghai, China (J.G.); Cumming School of Medicine and Libin Cardiovascular Institute, University of Calgary, Calgary, AB (J.G.H.), the Department of Cardiology, Montreal Heart Institute, Montreal (E.O.), and the Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, Toronto (S.V.) - all in Canada; Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria (T.K.); the Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan (M.K.); the Department of Molecular and Clinical Medicine and Cardiology, Sahlgrenska Academy (C.E.A.L.), and AstraZeneca (O.B., M. Sjöstrand, A.M.L.), Gothenburg, and the Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University (C.H.), Uppsala - all in Sweden; the Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M.); Instituto do Coracao, Hospital das Clinicas da Faculdade de Medicina, Universidade de São Paolo, São Paolo (J.C.N.); the Department of Internal Medicine, Tan Tao University, Tan Duc, Vietnam (P.N.V.); the Department of Myocardial Disease and Heart Failure, National Medical Research Center of Cardiology, Moscow (S.T.); and the Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison (D.L.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1911303DOI Listing
November 2019

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

N Engl J Med 2019 10 1;381(17):1609-1620. Epub 2019 Sep 1.

From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston (S.D.S., M.A.P., A.S.D., B.C.); the British Heart Foundation Cardiovascular Research Centre (J.J.V.M., P.S.J.) and the Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Well-being (J.C.), University of Glasgow, Glasgow, and the National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London (J.C.) - all in the United Kingdom; University of Minnesota, Minneapolis (I.S.A), and Mayo Clinic, Rochester (M.M.R.) - both in Minnesota; Shanghai Institute of Cardiovascular Diseases (J. Ge) and the Department of Cardiology (J.Z.), Zhongshan Hospital, Fudan University, Shanghai, China; National Heart Center Singapore and Duke-National University of Singapore, Singapore (C.S.P.L); National Association of Hospital Cardiologists Research Center, Florence (A.P.M.), and the Cardiology Division, Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo (M.S.) - both in Italy; National University of Cordoba, Cordoba, Argentina (F.M.); Baylor University Medical Center, Dallas (M.P.); the Department of Internal Medicine and Cardiology, German Center for Cardiovascular Research partner site Berlin (B.P.), and the Department of Cardiology, Charité Universitätsmedizin, Campus Virchow-Klinikum (H.-D.D.) - both in Berlin; Institut de Cardiologie de Montréal, Université de Montréal, Montreal (J.L.R.); the Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (D.J.V.); INSERM Centre d'Investigation Clinic 1433 and Université de Lorraine, Centre Hospitalier Régional et Universitaire, Nancy, France (F.Z.); Medical University of South Carolina and the Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston (M.R.Z.); National Research Center for Cardiology of the Ministry of Health of the Russian Federation, Moscow (S.A.B.); Community Heart Failure Program, Department of Cardiology, Bellvitge University Hospital and Bellvitge Institute for Biomedical Research, University of Barcelona, Barcelona (J.C.-C.); Department of Heart Failure-Transplantation, National Cardiovascular Institute, Bratislava, Slovakia (E.G.); Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria (T.K.); Disciplina de Cardiologia Faculdade de Medicina Pontifícia Universidade Católica de Campinas, São Paulo (J.F.K.S.); the Department of Noninvasive Cardiology, Medical University of Lodz, Lodz, Poland (M.L.); Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M.); Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago (S.J.S); and Novartis Pharmaceuticals, East Hanover, NJ (A.R.R., J. Gong, V.C.S., M.P.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1908655DOI Listing
October 2019

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction.

Clin Res Cardiol 2019 Aug 28;108(8):868-877. Epub 2019 Jan 28.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-019-01415-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652172PMC
August 2019

Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.

Circulation 2019 Aug 20;140(7):542-552. Epub 2019 Jun 20.

Institute of Cardiovascular and Medical Sciences (C.W., C.A.C.-M., R.B., P.B.M., S.R.G., L.D.F., P.S.J., J.M.R.G., N.S., P.W.), University of Glasgow, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.041149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693929PMC
August 2019

Healthcare disparities for women hospitalised with myocardial infarction and angina.

Eur Heart J Qual Care Clin Outcomes 2019 Jul 25. Epub 2019 Jul 25.

British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjqcco/qcz040DOI Listing
July 2019

Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.

JACC Heart Fail 2019 Jun 8;7(6):457-465. Epub 2019 May 8.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.02.015DOI Listing
June 2019

Improving recruitment for clinical trials: the human touch.

Authors:
Pardeep S Jhund

Med J Aust 2019 05 8;210(9):401-402. Epub 2019 May 8.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja2.50161DOI Listing
May 2019

Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis.

JACC Heart Fail 2019 04 6;7(4):336-346. Epub 2019 Feb 6.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2018.11.005DOI Listing
April 2019

Diabetic cardiomyopathy.

Heart 2019 Feb 18;105(4):337-345. Epub 2018 Oct 18.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2016-310342
Publisher Site
http://dx.doi.org/10.1136/heartjnl-2016-310342DOI Listing
February 2019

Contemporary Management of Heart Failure in the Elderly.

Drugs Aging 2019 02;36(2):137-146

British Heart Foundation Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40266-018-0625-4
Publisher Site
http://dx.doi.org/10.1007/s40266-018-0625-4DOI Listing
February 2019

Early use of mineralocorticoid receptor antagonists in ST-elevation myocardial infarction: is it ever too early?

Heart 2018 11 14;104(22):1812-1813. Epub 2018 May 14.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2018-313371DOI Listing
November 2018

Association is not causation: treatment effects cannot be estimated from observational data in heart failure.

Eur Heart J 2018 10;39(37):3417-3438

British Heart Foundation Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehy407DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166137PMC
October 2018

Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA.

Eur Heart J 2018 Oct 23. Epub 2018 Oct 23.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehy609DOI Listing
October 2018

Catheter Ablation for Atrial Fibrillation with Heart Failure.

N Engl J Med 2018 08;379(5):491-2

University of Glasgow, Glasgow, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1806519DOI Listing
August 2018

Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.

Eur J Heart Fail 2018 07 1;20(7):1139-1145. Epub 2018 Mar 1.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1160DOI Listing
July 2018

Risk of Incident Heart Failure in Patients With Diabetes and Asymptomatic Left Ventricular Systolic Dysfunction.

Diabetes Care 2018 06 6;41(6):1285-1291. Epub 2018 Apr 6.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc17-2583DOI Listing
June 2018

Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.

JACC Heart Fail 2018 06 11;6(6):489-498. Epub 2018 Apr 11.

British Heart Foundation (BHF) Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2018.02.004DOI Listing
June 2018

Association of Total and Differential Leukocyte Counts With Cardiovascular Disease and Mortality in the UK Biobank.

Arterioscler Thromb Vasc Biol 2018 06 26;38(6):1415-1423. Epub 2018 Apr 26.

From the Institute of Cardiovascular and Medical Sciences (P.W., C.W., P.B.M., C.A.C.-M., S.R.G., S.I., J.M.R.G., P.S.J., N.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.118.310945DOI Listing
June 2018

Peripartum cardiomyopathy: diagnosis and management.

Heart 2018 05 9;104(9):779-786. Epub 2017 Nov 9.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2016-310599DOI Listing
May 2018

Analysing registries in heart failure: The case of angiotensin receptor blockers in Asians with heart failure with reduced ejection fraction.

Authors:
Pardeep S Jhund

Int J Cardiol 2018 04;257:224-225

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2018.01.061DOI Listing
April 2018

Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality.

Eur J Heart Fail 2018 02 4;20(2):295-303. Epub 2017 Sep 4.

British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.901DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826811PMC
February 2018

Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.

Heart 2018 01 6;104(2):144-150. Epub 2017 Oct 6.

Golden Jubilee National Hospital, Queen Elizabeth University Hospital, Glasgow, Clydebank, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2016-310850DOI Listing
January 2018

Evidence-Based Therapy and Its Association With Workforce Detachment After First Hospitalization for Heart Failure.

JACC Heart Fail 2018 01 6;6(1):41-48. Epub 2017 Dec 6.

Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2017.09.019DOI Listing
January 2018

Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes.

Cardiovasc Drugs Ther 2017 Dec;31(5-6):545-549

British Heart Foundation Cardiovascular Research Centre, Institute of Cardiovascular and Medial Sciences, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10557-017-6754-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730631PMC
December 2017

Heart Failure in Young Adults Is Associated With High Mortality: A Contemporary Population-Level Analysis.

Can J Cardiol 2017 11 19;33(11):1472-1477. Epub 2017 Jun 19.

Division of Cardiology and Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada; Canadian Vigour Centre, University of Alberta, Edmonton, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2017.05.009DOI Listing
November 2017

Declining Risk of Sudden Death in Heart Failure.

N Engl J Med 2017 11;377(18):1794-5

University of Glasgow, Glasgow, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1711901DOI Listing
November 2017

Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.

Circ Heart Fail 2017 Nov;10(11)

From the BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (L.S., P.S.J., J.J.V.M.); Instituto do Coração (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil (F.R.); Instituto DAMIC/Fundacion Rusculleda, Cordoba, Argentina (F.M.); Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil (L.C.B.); Grupo de Ciencias Cardiovasculares, Fundación Cardiovascular de Colombia, Santander (L.E.E.); Clinica Shaio, Bogota, Colombia (E.A.G.); Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, Ohio State University, Columbus (W.T.A.); Stavanger University Hospital, University of Bergen, Norway (K.D.); Rigshospitalet Copenhagen University Hospital, Denmark (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX (M.P.); Institut de Cardiologie de Montréal, Université de Montréal, Canada (J.L.R.); Cardiovascular Medicine, Brigham and Women's Hospital, Boston MA (S.D.S.); Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden (K.S.); National Heart and Lung Institute, Imperial College, London, United Kingdom (K.S.); Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston (M.R.Z.); and Novartis Pharma, Basel, Switzerland (C.R.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004361DOI Listing
November 2017

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.

Circ Heart Fail 2017 Oct;10(10)

From the BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.L.K., P.S.J., U.M.M., R.R., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., R.R., L.K.); The Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, Ohio State University, Columbus (W.TA.); Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.D., S.D.S.); Stavanger University Hospital, Stavanger, and Department of Clinical Science, the Institute of Internal Medicine, University of Bergen, Norway (K.D.); Institut de Cardiologie de Montréal, Université de Montréal, Canada (J.L.R.); Medical University of South Carolina and RHJ Department of Veterans Administration Medical Center, Charleston (M.R.Z.); Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden (K.S.); Faculty of Medicine, National Heart and Lung Institute, Imperial College, London, United Kingdom (K.S.); and Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX (M.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004409DOI Listing
October 2017

Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review.

Eur J Heart Fail 2017 09 30;19(9):1154-1163. Epub 2017 May 30.

British Heart Foundation, Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.839DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731779PMC
September 2017

Re-Examination of the BEST Trial Using Composite Outcomes, Including Emergency Department Visits.

JACC Heart Fail 2017 08;5(8):591-599

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2017.04.005DOI Listing
August 2017

Declining Risk of Sudden Death in Heart Failure.

N Engl J Med 2017 07;377(1):41-51

From the British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences (L.S., P.S.J., M.C.P., J.J.V.M.), and Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing (J.G.F.C.), University of Glasgow, the Department of Cardiology, Golden Jubilee National Hospital (M.C.P.), and the Cardiology Department, Glasgow Royal Infirmary (H.J.D.), Glasgow, and the National Heart and Lung Institute, Imperial College London, London (J.G.F.C.) - all in the United Kingdom; the Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (B.L.C., S.D.S.); the Department of Cardiovascular Research, Istituto di Ricovero e Cura a Carattere Scientifico-Istituto di Ricerche Farmacologiche Mario Negri, Milan (S.B., R.L.), Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.), and Maria Cecilia Hospital, Gruppo Villa Maria Care and Research, Ettore Sansavini Health Science Foundation, Cotignola (L.T.) - all in Italy; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Rikshospitalet University Hospital, Oslo (J.K.); the Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen (L.K.); Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas (M.P.); the Department of Medicine, University of Michigan, Ann Arbor (B.P.); the Center for Person-Centered Care (K.S.) and Sahlgrenska Academy (J.W.), University of Gothenburg, Gothenburg, Sweden; INSERM Centre d'Investigation Clinique 1433, Université de Lorraine and Centre Hospitalier Universitaire, Nancy, France (F.Z.); and the Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston (M.R.Z.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1609758
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1609758DOI Listing
July 2017

Obesity and heart failure: when 'epidemics' collide.

Authors:
Pardeep S Jhund

Eur Heart J 2017 06;38(24):1934-1936

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehw357DOI Listing
June 2017

How robust are clinical trials in heart failure?

Eur Heart J 2017 02;38(5):338-345

Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehw427DOI Listing
February 2017

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).

Circulation 2017 Feb 4;135(8):724-735. Epub 2017 Jan 4.

From BHF Cardiovascular Research Centre, University of Glasgow, Scotland, UK (S.L.K., U.M.M., P.S.J., M.C.P., J.J.V.M.); Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., L.K.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK (D.P.); Mayo Clinic, Rochester, MN (S.W.); Western University, London, ON, Canada (R.S.M.); Ralph H. Johnsons Veterans Affairs Medical Center and Medical University of South Carolina, Charleston (M.R.Z.); Division of Cardiology, University of Minnesota, Minneapolis (I.S.A.); Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France (M.K.); University of Maryland Medical Center, Baltimore (J.S.G.); and Georgetown University and Washington DC Veterans Affairs Medical Center (P.E.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024593DOI Listing
February 2017

After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.

Eur Heart J 2016 Nov 13;37(41):3135-3140. Epub 2016 Apr 13.

British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehw114DOI Listing
November 2016

Geographic variation in heart failure-a matter of celebration or condemnation?

Authors:
Pardeep S Jhund

Eur J Heart Fail 2016 11;18(11):1329-1330

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.652DOI Listing
November 2016

Return to the Workforce After First Hospitalization for Heart Failure: A Danish Nationwide Cohort Study.

Circulation 2016 Oct 9;134(14):999-1009. Epub 2016 Aug 9.

From Department of Cardiology, Rigshospitalet, University of Copenhagen, Denmark (R.R., E.L.F., U.M.M., L.K., S.L.K.); BHF Cardiovascular Research Centre, University of Glasgow, UK (C.W., U.M.M., M.C.P., P.S.J., J.J.V.M., S.L.K.); Department of Anesthesiology and Intensive Care Medicine, Cardiovascular Research Centre, Aalborg University Hospital, Denmark (K.K.); Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark (M.L., G.H.G.); Department of Public health, Section of Biostatistics, University of Copenhagen, Denmark (T.A.G.); and Department of Health, Science and Technology, Aalborg University, Denmark (C.T.-P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.021859DOI Listing
October 2016

The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan.

Heart 2016 09 20;102(17):1342-7. Epub 2016 May 20.

BHF Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2014-306775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013095PMC
September 2016

Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy.

Circ Heart Fail 2016 09;9(9)

From the BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (N.O., P.S.J., J.J.V.M.); Novartis Pharmaceutical Corporation, East Hanover, NJ (J.G., M.P.L., A.R.R., V.C.S.); Institut de Cardiologie de Montréal, Université de Montréal, Quebec, Canada (J.L.R.); Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden (K.S.); National Heart and Lung Institute, Imperial College, London, United Kingdom (K.S.); Medical University of South Carolina and RHJ Department of Veterans Administration Medical Center, Charleston (M.R.Z.); Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (S.D.S.); and Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX (M.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003212DOI Listing
September 2016

Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.

Eur J Heart Fail 2016 08 15;18(8):1021-31. Epub 2016 May 15.

Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.547DOI Listing
August 2016

Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).

Circulation 2016 Jun 20;133(23):2254-62. Epub 2016 Apr 20.

From BHF Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (N.O., P.S.J., J.J.V.M.); Novartis Pharmaceutical Corporation, East Hanover, NJ (J.G., M.P.L., A.R.R., V.C.S.); Institut de Cardiologie, Université de Montréal, Canada (J.L.R.); Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden and National Heart and Lung Institute, Imperial College, London, United Kingdom (K.S.); Medical University of South Carolina and RHJ Department of Veterans Administration Medical Center, Charleston, SC (M.R.Z.); Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (S.D.S.); and Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX (M.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.020729DOI Listing
June 2016

Has the 'epidemic' of heart failure been replaced by a tsunami of co-morbidities?

Eur J Heart Fail 2016 05 12;18(5):500-2. Epub 2016 Apr 12.

Maria Cecilia Hospital, GVM Care and Research, E.S. Health Science Foundation, Cotignola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.529DOI Listing
May 2016

Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart Failure: A Systematic Review.

Circ Heart Fail 2016 05;9(5)

From the British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (R.T.C., G.P.W., P.S.J., M.C.P., J.J.V.M.); and Division of Cardiology (N.M.H.) and Facutly of Medicine (F.H.), University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.115.002842DOI Listing
May 2016

Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.

Circ Heart Fail 2016 Jan;9(1)

From the Department of Medicine, Medical University of South Carolina, Charleston (M.R.Z., C.F.B.); RHJ Department of Veterans Affairs Medical Center, Charleston, SC (M.R.Z., C.F.B.); Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (P.S.J., B.L.C., S.D.S.); BHF Glasgow Cardiovascular Research Center, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (P.S.J., J.J.V.M.M.); Department of Cardiology, Medical University of Graz, Graz, Austria (B.P.); Department of Internal Medicine and Cardiology, Charité, Campus Virchow Klinikum, Berlin, Germany (B.P.); Department of Internal Medicine and Cardiology, German Heart Center, Berlin, Germany (B.P.); Department of Cardiology, University of Groningen, Groningen, The Netherlands (A.A.V.); and Novartis Pharmaceuticals, East Hanover, NJ (M.F.P., V.S., M.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.115.002551DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485256PMC
January 2016

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.

Circ Heart Fail 2016 Jan;9(1)

From the British Heart Foundation, Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (S.L.K., D.P., P.J., J.J.V.M.); Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark (S.L.K.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK (I.S.); NIHR Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK (I.S.); Department of Cardiology, Porto Medical School, Porto, Portugal (J.S.C.); Heart and Vascular Center Semmelweiss University, Budapest, Hungary (B.M.); Instituo DAMIC, Cordoba National University, Cordoba, Argentina (F.M.); Kaufman Center for Heart Failure, Heart and Vascular Institute, Cleveland Clinic, OH (R.C.S.); Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D); Novartis Pharmaceutical Corporation, East Hanover, NJ (M.P.L., A.R.R., V.C.S.); Institut de Cardiologie, Université de Montréal, Montréal, Québec, Canada (J.L.R.); Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden (K.S.); RHJ Department of Veterans Administration Medical Center, Medical University of South Carolina, Charleston (M.R.Z.); and Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (M.P.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.115
Publisher Site
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.115.002560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718182PMC
January 2016

What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?

Open Heart 2015 23;2(1):e000283. Epub 2015 Dec 23.

British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow , Glasgow , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/openhrt-2015-000283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692046PMC
December 2015